Glucotrack, Inc. — Form 8-K
Filed September 11, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
On September 10, 2026, Glucotrack issued a senior secured convertible promissory note with 22% original issue discount (OID), 8% annual interest, 9-month maturity, convertible into common stock. Note principal amount is blank (unfunded). Concurrent warrant issuance at $7.50 exercise price. CEO Erik Emerson signed. Holder entitled to repayment from 100% of proceeds from asset sales, debt, equity issuances, and deposits, with 3-day payment deadline or event of default. Most-favored-nation provision auto-adjusts terms if company issues better terms.
Why this rating
Financing is material (unfunded amount unclear) relative to $5.4M market cap. Aggressive terms—125% default rate, lien on all assets, conversion caps—suggest distress. Stock price uncertainty depends on amount and burn rate.
Price action (we called it neutral)
before filing · preread $2.55 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.